Doctor profile · Federal record
Dr. Jason Karp, MD
Pulmonary Disease Physician (CMS: Pulmonary Disease) · Critical Care Medicine (Internal Medicine) Physician · Lake Success, NY
- NPI 1376514265
- Accepts Medicare
- MIPS 85.0 / 100 · 2023
- 38 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
6 Ohio Dr, Suite 201
Lake Success, NY 110421129
(516) 328-8700
fax (516) 328-8779
Credentials & registration
- NPI registered
- January 2006 — 20 yrs on file
- Profile last updated
- September 2, 2008
- Year of graduation
- 1988 — 38 yrs since
- Specialty taxonomy
- 207RP1001X — NUCC code
- State license (1)
- New York #179910
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1376514265. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
82,121
Distinct HCPCS
10
Medicare allowed
$2,660,613
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J2356 |
Injection, tezepelumab-ekko, 1 mg | 44,310 | 36 | $18 | |
J2182 |
Injection, mepolizumab, 1 mg | 18,500 | 29 | $29 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 4,483 | 2,106 | $148 | |
94010 |
Test to measure expiratory airflow and volume | 3,987 | 2,118 | $32 | |
95012 |
Test to measure the level of nitric oxide gas | 3,653 | 2,029 | $23 | |
94729 |
Test to examine how well the lungs exchange gases | 2,130 | 1,725 | $68 | |
94727 |
Test to determine lung volumes using gas dilution or washout | 2,103 | 1,710 | $52 | |
94618 |
Test for exercise-induced lung stress | 608 | 573 | $39 | |
96372 |
Injection of drug or substance under skin or into muscle | 529 | 81 | $17 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 503 | 91 | $91 |
In context: peer comparison
Among 7 peers in Lake Success Pulmonary Disease Physician, average services per provider: 906. This provider delivers 91× the peer median.Open Payments
Industry payments received
All-time total
$996
Transactions
9
Manufacturers
7
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Amgen INC. | 2 | $232.00 | |
| Actelion Pharmaceuticals US, INC. | 2 | $198.02 | |
| 3B Medical, INC. | 1 | $134.64 | |
| GlaxoSmithKline, LLC. | 1 | $113.97 | |
| Philips North America LLC | 1 | $108.99 | |
| Inspire Medical Systems, INC. | 1 | $108.45 | |
| AstraZeneca Pharmaceuticals Lp | 1 | $100.00 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
8,841
Patients
3,456
Total drug cost
$2,963,411
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Montelukast Sodium | Generic | 1,679 | 572 | $30,478 |
| Famotidine | Generic | 1,190 | 495 | $24,774 |
| Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) | Brand | 1,145 | 367 | $1,336,545 |
| Prednisone | Generic | 789 | 453 | $5,798 |
| Albuterol Sulfate Hfa (Albuterol Sulfate) | Brand | 632 | 285 | $32,726 |
| Breo Ellipta (Fluticasone/Vilanterol) | Brand | 570 | 182 | $416,060 |
| Symbicort (Budesonide/Formoterol Fumarate) | Brand | 517 | 200 | $384,660 |
| Azelastine Hcl | Generic | 345 | 158 | $20,288 |
| Anoro Ellipta (Umeclidinium Brm/Vilanterol Tr) | Brand | 339 | 108 | $307,186 |
| Levocetirizine Dihydrochloride | Generic | 308 | 113 | $6,151 |
Hospital affiliations
Frequently asked questions
What is Dr. Jason Karp's medical specialty?
Dr. Jason Karp practices Pulmonary Disease Physician in Lake Success, NY.
Where does Dr. Jason Karp practice?
Dr. Jason Karp practices at 6 Ohio Dr, Lake Success, NY 110421129. Office phone: 5163288700.
What is Dr. Jason Karp's NPI?
Dr. Jason Karp's National Provider Identifier (NPI) is 1376514265, issued by NPPES.
Does Dr. Jason Karp accept Medicare assignment?
Yes. Dr. Jason Karp accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Jason Karp commonly perform?
Top Medicare-reported procedures in 2023: Injection, tezepelumab-ekko, 1 mg (HCPCS J2356); Injection, mepolizumab, 1 mg (HCPCS J2182); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.